PharmiWeb.com - Global Pharma News & Resources
01-Nov-2018

Presenting Companies Announced for 2018 Texas Life Science Forum

BioHouston and Rice University’s Rice Alliance for Technology and Entrepreneurship are partnering together for the annual showcase of the most promising life science, medical device and digital health companies, as well as the Texas Medical Center’s entrepreneurship ecosystem on Thursday, November 8 at the BioScience Research Collaborative (BRC) at Rice University. Sixty-one early and late-stage life science companies who have collectively already raised more than $176 million in funding will present their business concepts to hundreds of life science investors, entrepreneurs, and leaders from around the country.

   

What:

Texas Life Science Forum
 

When:

Thursday, Nov. 8, 2018, 8 AM – 5:30 PM
 

Where:

Texas Life Science Forum – BioScience Research Collaborative, Rice University,
6500 Main St., Houston
 
       

Presenting Companies:

 
206 Ortho

Intelligent Implants

Adroit Surgical K94 Discoveries
AesculaTech Life Warmer
Affigen Nanospectra Biosciences
Agilvax NERv Technology
Airway Medical Innovations Netnoids Rx Laboratories
Amina Health Noleus Technologies
Aperta Biosciences Noninvasix
AuriGen Medical Novelus Biotechnology
Aviara Pharmaceuticals OcciGuide
Beta Cat Pharmaceuticals Odin Technologies
BioAesthetics Patients We Share
BioCapital Holdings Pegwin
BioLum Sciences PolyVascular
BrainCheck rHDL Technologies
BreviTest Technologies SafKan - Ear Care
Concure Oncology Salarius Pharmaceuticals
Cord Blood Plus Sana Health
CorInnova Saranas
D&P Bioinnovations Simergent
DiaStem Siva Therapeutics
Entvantage Diagnostics Spitfire Pharma
Esperance Pharmaceuticals Stream Biomedical
Evaheart Theratome Bio
Forbius Twister Biotech
Forward Science Vax-Immune
Gold Flex Life Sciences VenoStent
Harmonic Bionics VerteCore
HealthTech Solutions (HTS) Volumetric
Immatics US Zennea
Inpro Medical
 

This event will bring together top medical innovators, life science companies, investors, hospital executives, entrepreneurs, board members, clinical thought-leaders, and researchers from the TMC and across the country to discuss today’s most pressing health challenges and share their innovation solutions.

About the Texas Life Science Forum:

The Texas Life Science Forum is the premier life science event in Texas that brings together members from industry, emerging life science companies, academic, and investors. This event represents an opportunity to meet investors, learn about promising life science companies, network and learn about opportunities for entrepreneurs, investment professionals, big pharma, academics and business executives serving the life science industry. The Texas Life Science Forum is supported by the Texas Medical Center, TMC Innovation Institute, Insperity, Houston Exponential, Station Houston, and many other supporters and academic institutions in the Texas Region.

About BioHouston:

BioHouston, Inc. is a non-profit tax-exempt [501(c)(3)] corporation founded by Houston area academic/research institutions. BioHouston leads a broad effort to establish the Houston region as a vigorous global competitor in life science and biotechnology commercialization. BioHouston’s mission is to create an environment that will stimulate technology transfer and research commercialization, thereby generating economic wealth for the Houston region and making it a global competitor in life science commercialization. BioHouston’s activities provide the greatest leverage in making the Houston region a world-class competitor in the life science industry.

About the Rice Alliance for Technology and Entrepreneurship

The Rice Alliance for Technology and Entrepreneurship is Rice University’s globally recognized initiative devoted to the support of technology commercialization, entrepreneurship education and the launch of technology companies. Since inception in 1999, more than 2,300 early-stage companies have participated at the 185+ programs hosted by the Rice Alliance and raised more than $7.1 billion in funding.

View source version on businesswire.com: https://www.businesswire.com/news/home/20181101005755/en/

Editor Details

Last Updated: 01-Nov-2018